Inhibition of CBLB protects from lethal Candida albicans sepsis

G. Wirnsberger, F. Zwolanek, T. Asaoka, I. Kozieradzki, L. Tortola, R.A. Wimmer, A. Kavirayani, F. Fresser, G. Baier, Wallace Y. Langdon, F. Ikeda, K. Kuchler, J.M. Penninger

    Research output: Contribution to journalArticlepeer-review

    81 Citations (Scopus)


    Fungal infections claim an estimated 1.5 million lives each year. Mechanisms that protect from fungal infections are still elusive. Recognition of fungal pathogens relies on C-Type lectin receptors (CLRs) and their downstream signaling kinase SYK. Here we report that the E3 ubiquitin ligase CBLB controls proximal CLR signaling in macrophages and dendritic cells. We show that CBLB associates with SYK and ubiquitinates SYK, dectin-1, and dectin-2 after fungal recognition. Functionally, CBLB deficiency results in increased inflammasome activation, enhanced reactive oxygen species production, and increased fungal killing. Genetic deletion of Cblb protects mice from morbidity caused by cutaneous infection and markedly improves survival after a lethal systemic infection with Candida albicans. On the basis of these findings, we engineered a cell-permeable CBLB inhibitory peptide that protects mice from lethal C. albicans infections. We thus describe a key role for Cblb in the regulation of innate antifungal immunity and establish a novel paradigm for the treatment of fungal sepsis.
    Original languageEnglish
    Pages (from-to)915-923
    Number of pages9
    JournalNature Medicine
    Issue number8
    Publication statusPublished - 1 Aug 2016


    Dive into the research topics of 'Inhibition of CBLB protects from lethal Candida albicans sepsis'. Together they form a unique fingerprint.

    Cite this